Purpose: To determine patients' knowledge and attitudes towards patien
t-controlled analgesia,(PCA) costs through the use of our acute pain s
ervice quality assurance (QA) programme. Methods: Quality Assurance qu
estionnaires were distributed to all patients receiving PCA opioids fo
r >12 hr. Patients were asked to note the presence of side effects (na
usea/vomiting, pruritus, urinary retention), to indicate their satisfa
ction with regard to their pain relief, follow-up assessments, treatme
nt of side effects, and to recall the previous method of pain relief a
nd their satisfaction with it. Patients were also asked to estimate th
e total cost of PCA (0-$50, $50-100, $100-200, >$200), and what amount
if any they would be willing to pay (0-$50, $50-100, $100-200, >$200)
. Results obtained over a recent four month period were reviewed. Resu
lts: One hundred and thirty-three questionnaires were distributed and
103 (77%) were returned. The percentage of patients rating their satis
faction as very good or excellent was 86% for pain relief, 96% for fol
low-up, 71% for side effect treatment, but only 43% for their previous
surgical pain relief (P<0.001). The distribution of cost estimates wa
s 10% $50-100, 37% $100-200 and 53% >$200 with 60% willing to pay a po
rtion of this cost. Those willing to pay were more likely to have had
very good or excellent pain relief (94% vs 71%, P<0.05) and treatment
of side effects (71% vs 48%, P<0.05) than those not willing to pay. Co
nclusions: Patients continue to be highly satisfied with PCA therapy a
nd are aware of the costs involved. A majority of patients were willin
g to pay to obtain this service if necessary. Patients who had poorer
pain relief and less efficacious treatment of their side effects were
less willing to pay.